Type 2 diabetes is characterized by hyperglycemia and damage to small blood vessels and nerves. Many patients are asymptomatic. Common symptoms include frequent urination, increased thirst, fatigue, and weight loss. Screening should be considered for overweight adults with additional risk factors such as high blood pressure, dyslipidemia, or a family history of diabetes. Treatment involves lifestyle changes like diet and exercise as well as oral medications like metformin, sulfonylureas, or DPP-4 inhibitors to control blood sugar levels.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPTX, PDF, TXT or read online from Scribd
Type 2 diabetes is characterized by hyperglycemia and damage to small blood vessels and nerves. Many patients are asymptomatic. Common symptoms include frequent urination, increased thirst, fatigue, and weight loss. Screening should be considered for overweight adults with additional risk factors such as high blood pressure, dyslipidemia, or a family history of diabetes. Treatment involves lifestyle changes like diet and exercise as well as oral medications like metformin, sulfonylureas, or DPP-4 inhibitors to control blood sugar levels.
Type 2 diabetes is characterized by hyperglycemia and damage to small blood vessels and nerves. Many patients are asymptomatic. Common symptoms include frequent urination, increased thirst, fatigue, and weight loss. Screening should be considered for overweight adults with additional risk factors such as high blood pressure, dyslipidemia, or a family history of diabetes. Treatment involves lifestyle changes like diet and exercise as well as oral medications like metformin, sulfonylureas, or DPP-4 inhibitors to control blood sugar levels.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPTX, PDF, TXT or read online from Scribd
Type 2 diabetes is characterized by hyperglycemia and damage to small blood vessels and nerves. Many patients are asymptomatic. Common symptoms include frequent urination, increased thirst, fatigue, and weight loss. Screening should be considered for overweight adults with additional risk factors such as high blood pressure, dyslipidemia, or a family history of diabetes. Treatment involves lifestyle changes like diet and exercise as well as oral medications like metformin, sulfonylureas, or DPP-4 inhibitors to control blood sugar levels.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 14
DIABETES MELLITUS
Type 2 in adults INTRODUCTION
Type 2 diabetes mellitus is a group of
disorders characterized by: hyperglycemias micro vascular (retinal, renal, possibly neuropathic) macro vascular (coronary, cerebrovascular, peripheral vascular) neuropathic (autonomic, peripheral) PATHOGENESIS ENUMERATE SYMPTOMS SYMPTOMS OF DIABETES Fourty eight percent (48%) of patients above the age of 30 years old are not aware that they have diabetes. The majority are asymptomatic. Common symptoms include polyuria, polydipsia, tiredness and weight loss Acute Complications a) Hypoglycaemia b) Hyperglycaemia DIAGNOSTIC CRITERIA •Random plasma glucose >11.1mmole/L •Fasting plasma glucose >7mmole/L •Result of GTT after oral intake 75g glucose in 2 hours >11.1mmole/L WHO TO SCREEN??? Testing should be considered in all adults who are overweight. (BMI) >23 kg/m2 or waist circumference ≥80 cm for women & ≥90 cm for men and have additional risk factors: Dyslipidaemia either high density lipoprotein (HDL) <0.9 mmol/L or triglycerides (TG) >1.7 mmol/L History of cardiovascular disease (CVD) Hypertension (≥140/90 mmHg or on therapy for hypertension) Impaired Glucose Tolerance (IGT) or Impaired Fasting Glucose (IFG) First-degree relative with diabetes Other clinical conditions associated with insulin resistance (e.g. severe obesity and acanthosis nigricans) Physical inactivity Women with polycystic ovarian syndrome (PCOS) NEXT? FPG Glycosylated Haemoglobin (HbA1c) Renal profile Lipid profile Urine analysis particularly for albuminuria Electrocardiogram (ECG) SYNDROMES Syndrome of severe insulin secretion deficiency Paradiabetic syndrome AKA syndrome of small signs Syndrome of late diabetic complication Diabetic foot syndrome ORAL ANTI-DIABETIC (OAD) AGENTS There are currently five classes of OAD agents: AGIs (alpha glucosidase inhibitors) ACARBOSE100mg TDS Biguanides METFORMIN2000mg OD Dipeptidyl peptidase-4 (DPP-4) Inhibitors SITAGLIPTIN 100mg OD GLP-1 analogue BAETTA aka exanetide Insulin Secretatogues aka (SU) GLIBENCLAMIDE 10mgBD Insulin Secretagogues- (Non-SU) or Meglitinides REPAGLINIDE 4mg with main meals (o.5mg per meal) Thiazolidinediones (TZDs) ROSIGLITAZONE 4mg BD LIVE HEALTHY